These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16895705)

  • 1. [The evolution of the hypervariable region-1 of hepatitis C virus may predict liver fibrosis outcome after renal transplantation].
    Kamar N; Rostaing L; Selves J; Sandres-Saune K; Alric L; Durand D; Izopet J
    Nephrol Ther; 2005 Dec; 1(6):345-54. PubMed ID: 16895705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation?
    Kamar N; Selves J; Sandres-Saune K; Durand D; Izopet J; Rostaing L
    Transplant Proc; 2006 Jun; 38(5):1329-32. PubMed ID: 16797294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.
    Kamar N; Rostaing L; Selves J; Sandres-Saune K; Alric L; Durand D; Izopet J
    Am J Transplant; 2005 Jul; 5(7):1704-12. PubMed ID: 15943629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.
    Izopet J; Rostaing L; Sandres K; Cisterne JM; Pasquier C; Rumeau JL; Duffaut M; Durand D; Puel J
    J Infect Dis; 2000 Mar; 181(3):852-8. PubMed ID: 10720504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
    Wali MH; Heydtmann M; Harrison RF; Gunson BK; Mutimer DJ
    Liver Transpl; 2003 Aug; 9(8):796-804. PubMed ID: 12884191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
    Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
    Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
    Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
    Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G
    J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
    Delladetsima I; Psichogiou M; Sypsa V; Psimenou E; Kostakis A; Hatzakis A; Boletis JN
    Am J Kidney Dis; 2006 Feb; 47(2):309-16. PubMed ID: 16431260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
    Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
    Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
    Sulkowski MS; Mehta SH; Torbenson MS; Higgins Y; Brinkley SC; de Oca RM; Moore RD; Afdhal NH; Thomas DL
    AIDS; 2007 Oct; 21(16):2209-16. PubMed ID: 18090048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
    Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
    Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis.
    Kamar N; Rostaing L; Boulestin A; Sandres K; Dubois M; Ribes D; Modesto A; Durand D; Izopet J
    J Med Virol; 2003 Apr; 69(4):482-8. PubMed ID: 12601755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patients infected with hepatitis C virus.
    Boyacioğlu S; Gür G; Yilmaz U; Korkmaz M; Demirhan B; Bilezikçi B; Ozdemir N
    Transplant Proc; 2004; 36(1):50-2. PubMed ID: 15013298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.